Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-04-24 pm EDT 5-day change 1st Jan Change
577.4 USD +0.49% Intraday chart for Thermo Fisher Scientific +4.12% +8.78%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Wolfe Research Raises Thermo Fisher Scientific's Price Target to $625 From $615 MT
Baird Trims Thermo Fisher Scientific's Price Target to $620 From $621 MT
Top Midday Stories: Tesla, Boston Scientific Shares Jump Post-Earnings; Major Airline Stocks Down on New DOT Rules; B. Riley Finally Submits 10-K, Sends Stock Soaring MT
Global markets live: Heineken, AT&T Hasbro, Visa, Boeing... Our Logo
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $615 From $610 MT
Transcript : Thermo Fisher Scientific Inc., Q1 2024 Earnings Call, Apr 24, 2024
Futures Mostly Rise in Premarket Ahead of More Corporate Earnings; Asia, Europe Up MT
Tech Strength Lifts Wall Street Pre-Bell; Asia Rallies, Europe Up MT
Thermo Fisher lifts profit forecast as medical equipment demand improves RE
Thermo Fisher's Fiscal Q1 Adjusted Earnings Rise While Revenue Falls; Fiscal 2024 Outlook Updated -- Shares Advance Pre-Bell MT
Thermo Fisher Scientific 1Q Revenue Tops Estimates, Raises 2024 Outlook DJ
Earnings Flash (TMO) THERMO FISHER SCIENTIFIC Reports Q1 Revenue $10.35B, vs. Street Est of $10.18B MT
Earnings Flash (TMO) THERMO FISHER SCIENTIFIC Reports Q1 EPS $5.11, vs. Street Est of $4.71 MT
Thermo Fisher Scientific Inc. Raises Revenue Guidance for the Full Year 2024 CI
Bernstein Adjusts Price Target on Thermo Fisher Scientific to $544 From $520, Market Perform Rating Kept MT
Baird Adjusts Price Target on Thermo Fisher Scientific to $621 From $597 MT
TD Cowen Raises Price Target on Thermo Fisher Scientific to $644 From $612 MT
HSBC Adjusts Thermo Fisher Scientific Price Target to $660 From $630 MT
Thermo Fisher Scientific Inc. Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing CI
Thermo Fisher Scientific Receives Shareholder Proposal from John Chevedden CI
Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis Across Life Sciences, Applied and Industrial Markets CI
RBC Raises Price Target on Thermo Fisher Scientific to $657 From $642, Keeps Outperform Rating MT
Thermo Fisher Scientific Introduces Its Newest Line of High Performance, Ultra-Low Temperature Freezers CI
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period MT
South Korean Trade Ministry, Thermo Fisher Scientific Explore Potential for Raw Biomaterials Facility MT
Chart Thermo Fisher Scientific
More charts
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
577.4 USD
Average target price
611.4 USD
Spread / Average Target
+5.89%
Consensus
  1. Stock Market
  2. Equities
  3. TMO Stock
  4. News Thermo Fisher Scientific
  5. Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday